| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $716.0M | +5.8% |
| SG&A Expense | $119.0M | -7.8% |
| Operating Income | -$835.0M | +54.9% |
| Pre-tax Income | -$796.0M | +53.8% |
| Income Tax | $0 | — |
| Net Income | -$796.0M | +53.8% |
| EPS (Basic) | -$0.60 | +60.3% |
| EPS (Diluted) | -$0.60 | +60.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $501.0M | +91.2% |
| Current Assets | $1.22B | +8.9% |
| Total Assets | $2.23B | +11.7% |
| Current Liabilities | $111.0M | +33.7% |
| Total Liabilities | $250.0M | +15.2% |
| Stockholders' Equity | $1.99B | +11.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$598.0M | -17.7% |
| Capital Expenditures | $15.0M | +0.0% |
| Investing Cash Flow | $8.0M | +100.9% |
| Financing Cash Flow | $831.0M | +7454.5% |
| Free Cash Flow | -$613.0M | -17.2% |